Status:
COMPLETED
Comparing Dexmedetomidine With Bupivacaine Versus Bupivacaine Alone for Caudal Block in Supra - Umbilical Surgeries
Lead Sponsor:
Cairo University
Conditions:
Anesthesia
Eligibility:
All Genders
1-6 years
Phase:
PHASE2
PHASE3
Brief Summary
dexmedetomidine is an alpha 2 adrenergic receptor agonist that is given either systemically or combined to local anesthetics during regional blocks. Investigators studied the combination of dexmedetom...
Detailed Description
Dexmedetomidine was combined to bupivavaine and administered via caudal route to be compared to caudal bupivavaine alone for analgesia following upper trunk surgery
Eligibility Criteria
Inclusion
- supra - umbilical surgeries
Exclusion
- allergy to the drug or coagulopathy
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2017
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT03307590
Start Date
October 1 2017
End Date
December 30 2017
Last Update
July 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt